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The autumn 2004 session of the American College for
Advancement in Medicine’s 162nd International Educational
Conference on Complementary, Alternative and Integrative
Medicine (CAIM) took place November 17–21, 2004 at the
Sheraton San Diego Hotel and Marina in San Diego, California,
USA. This event served as testament to the overwhelming profes-
sional interest in CAIM therapies and the science supporting
evidence-based CAIM therapies. Embraced by Southern
California’s warm sunny skies and temperate gentle breezes, over
500 physicians, health practitioners and medical professionals
convened at ACAM’s ‘A Blast to the Future—Emerging Concepts
in Immunology’ conference, in order to learn about the latest
science behind a wide variety of exciting new CAIM therapies.
The American College for Advancement in Medicine
(ACAM) is a not-for-profit medical society dedicated to educat-
ing physicians and other health care professionals on the latest
findings and emerging procedures in preventive/nutritional
medicine. As the voice of CAIM, ACAM strives to increase
awareness and recognition of CAIM therapies and play an active
role in shaping the future of the CAIM movement.
Celebrating more than a quarter century of service, ACAM
represents nearly 1000 physicians in 30 countries. ACAM is
the largest and oldest organization of its kind in the world ded-
icated to providing its members with educational excellence in
integrative medicine. ACAM’s leading edge educational pro-
gramming facilitates the incorporation of clinically relevant
biomedical therapies by fast tracking scientific advancements
in nutritional medicine, nutraceuticals and ethno-pharmacol-
ogy into the practice of cutting-edge CAIM.
ACAM was the first major medical organization to educate
its members about such now well accepted concepts as insulin
resistance/metabolic syndrome, the detrimental effects of
homocysteine, the protective effects of antioxidants, the clini-
cal uses of essential fatty acids, cancer chemoprotection thera-
pies with diet and herbs, testing for cardiosensitive C-reactive
protein, the benefits of natural thyroid replacement and nutri-
tional medicine as applied to psychiatry.
Scientific presentations at ACAM’s autumn 2004 convocation
addressed a multitude of topics relevant to physicians and sci-
entists interested in using CAIM therapies for the evaluation
and treatment for a wide variety of diseases. Presentations on
advances in laboratory medicine included the laboratory assess-
ment of complex diseases and the assessment of immune
integrity through evaluation of T- and B-cell subsets and natural
killer (NK) cell activity. CAIM treatments of cancer were
addressed through evaluating the efficacy of herbs and immune-
modulating peptide analogues in the treatment of cancer.
Colleen Hayes, PhD, Professor of Biochemistry and Medical
Microbiology in the Department of Biochemistry at the
University of Wisconsin-Madison and Chairperson for the
Department of Defense Breast Cancer Research Program in
the Cell Biology Study Section, presented a fascinating lecture
on vitamin D’s relationship to the endocrine system and
autoimmune diseases. She provided data from an animal
model of autoimmune encephalomyelitis and the pro-apoptotic
influence of 1,25-dihydroxyvitamin D3 on inflammatory cells
leading to their selective destruction.
Edwin Cooper, PhD, Distinguished Professor, Department
of Neuroimmunology at the David Geffen School of Medicine
at UCLA was presented with the Norman E. Clark Award for
Innovation in Medicine for his contributions to advancing the
field of CAIM and for his groundbreaking work as the
Founding Editor in Chief of eCAM. Neal Speight, MD,
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Dr Cooper also gave a keynote lecture on Emerging Concepts
in Immunology, where he reviewed the history of immunology
and its interface with various CAIM therapies.
A complete list of conference presentations can be found at
the end of this article.
In addition to the many exciting presentation at the scientific
conference, ACAM added a number of new and updated pre-
conference workshops to their quality line up of educational
programs. A highly popular 2-day mesotherapy workshop,
Chaired by ACAM’s President Dr Allan Magaziner, high-
lighted ACAM’s pre-conference workshops. Mesotherapy was
developed originally in France by Dr Michel Pistor and is
currently being administered by over 15 000 doctors in France.
Mesotherapy involves the injection of vitamins, minerals,
amino acids, homeopathics and other biologicals, and can help
with body sculpting, weight loss, cellulite reduction, wrinkle
reduction and facial rejuvenation. ACAM is the first medical
organization to teach a combination of classical mesotherapy,
bio-mesotherapy and lipodissolve at one conference.
Other new and updated workshops included ‘Integrating
Nutrition into Medical Practice’a 1-day workshop on integrat-
ing the fundamentals of nutrition into complementary and
alternative medicine clinical practice, and ‘Translating CAIM
into Practice: A Management/Legal Workshop’.
ACAM’s President, Dr Allan Magaziner commented,‘I’m
proud to say that our Fall 2004 ACAM convention in San
Diego was one of our best ever. There was a feeling of renewed
excitement and energy that was experienced by hundreds of
attendees and exhibitors. Participants were thrilled with the
professionalism, depth of cutting-edge knowledge and stellar
presentations that were shared by our scientific and clinical
speakers.’
ACAM is a professional medical organization for physicians
interested in learning about evidence-based CAIM therapies.
ACAM’s goals are to improve skills, knowledge and diagnostic
procedures as they relate to complementary and alternative medi-
cine; to support research; and to develop awareness of alternative
methods of medical treatment. ACAM’s next scientific conference
‘Menopause, Andropause: Power in Transition’ will be held
at Disney’s Coronado Spring Resort in Orlando, Florida, May
18–22, 2005. Workshop topics include Esthetic Mesotherapy,
Heavy Metals and Chelation Therapy and an in-depth Nutrition
Certification Seminar. For further information, please call ACAM
at 800-532-3688 (in the USA) or 949-583-7666 (outside the
USA) or register on line at http://www.acam.org
Summary of Presentations
Ari Vojdani PhD, MT
CEO of Immunosciences Labs, and Assistant Researcher at
the Department of Neurobiology at UCLA: “Laboratory of
Immunology for the Assessment of Complex Diseases”.
With more than 100 peer-reviewed articles and 20 patents to
his credit, Dr Vojdani reviewed the key role infections and
xenobiotics play in altering immune function and how they lead
to the development of complex disease states. The following
concepts were reviewed: (i) the cross-reactivity of tissues and
cellular antigens, including myelin basic protein- specific T cells,
with multiple microbial peptides; (ii) how haptenic chemicals
such as mercury can bind to different tissue antigens and
induce allergic and autoimmune reactions; (iii) the prototypic
Th2 autoimmunity induced by mercury and its dependence on
interferon (IFN)-  and other proinflammatory cytokines in
animal models and in children with autism; and (iv) the practical
assessment of the immune system in the setting of complex dis-
ease states utilizing testing for: T-cell helper/suppressor ratios,
antinuclear antibody (ANA), fibrillarin, chromatin, mercury,
neurofilament, tubulin and antibodies to neuron-specific anti-
gens. These and many other immunological tests were reviewed
for early diagnosis of autoimmune and neuroimmune diseases
induced by infections and toxic chemicals. Celiac, Crohn’s
disease, ulcerative colitis, myocarditis, lupus, multiple sclerosis
and Lyme disease were a few examples of the diseases, which
were discussed.
Mary Hardy, MD
A complementary and alternative medicine expert for research
projects conducted by the Southern California Evidence-based
Practice Center at the Land Corporation.
Herbs and Cancer
Dr Hardy reviewed the use of medicinal plants as chemopre-
ventative agents, the mechanisms by which plants can affect
the genesis of cancer, and the potential interaction between
medications and chemotherapy.
Dr Hardy reviewed the following concepts: (i) characteris-
tics of cancer and the stepwise nature of cancer development
with a major emphasis on mutations and proliferation; (ii) dif-
ferent opportunities for intervention using herbal therapies
which address different cellular and molecular targets involved
in the development of cancer; (iii) examples of natural chemo-
preventative agents such as green tea, panax ginseng, turmeric,
soy, medicinal mushrooms and their molecular mechanisms;
and (iv) immune enhancement properties of these agents, in
particular, medicinal mushrooms, on cell-mediated immunity.
Jesse Stoff, MD
Medical Doctor, Certified Naturopathic Physician,Acupuncturist
and Homeopathic Physician. Graduate of New York Medical
College and Fellow of Royal London Homeopathic Hospital in
London, UK.
Immune Reconstitution in the Face of Severe or
Chronic Disease
Dr Stoff’s presentation focused primarily on the assessment of
immune integrity through evaluation of T- and B-cell subsets,
and NK cell activity. He reviewed the patterns of immune dys-
function seen in various viral states and suggested therapies
designed to restore proper balance to the immune system
damaged by viral infections or heavy metal exposure.
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Visiting Scientist at North Carolina State University. Director
of the Clinical Research and Development at V-SAB Medical
Labs, Inc. Medical Director of Advanced Concepts in Medicine.
5 Step Non-traditional Medical Approach in the
Treatment of Cancer Utilizing Immune Modulating
Peptide Analogs
Dr Buttar’s lecture summarized the importance of preventive
approaches to cancer and emphasized that optimizing nutritional
and environmental balance prior to onset of cancer is the most
practical approach. He reviewed the common characteristics
of most cancers, the disruption of nutritional status and toxic
body burden that may contribute to oncogenesis, the impor-
tance of systemic optimization of the cancer patient, and mon-
itoring biological markers to assess efficacy of treatment. He
reviewed his peptide modulators and their potential benefit in
the management of cancer and also emphasized the potential
role of heavy metals in many cancers. Participants were very
interested in the structure of this peptide, which was not dis-
cussed during Dr Buttar’s presentation.
Farrand Robson, DDS
Member of the Washington State Dental Association, the ADA,
and the Academy of Head, Neck, and Facial Pain, A Fellow of
The International College of Cranio-mandibular Orthopedics,
and a Diplomat of The American Academy of Pain.
Systemic Implications of Oral Functions
Dr Robson reviewed the role of craniofacial anatomic
dysfunction and its influence on the autonomic nervous system
leading to commonly seen, but often mismanaged, illnesses
such as chronic headaches, upper back pain and fibromyalgia.
He emphasized the importance of proper occlusion, and how
malocclusion can frequently lead to systemic illness that often
manifests as sleep disordered breathing (SDB) and TMJ syn-
drome with its related problems. Finally, he provided a practical
solution to these problems utilizing a unique dental prosthesis
that is now clinically available.
Colleen Hayes, PhD
Professor of Biochemistry and Medical Microbiology in the
Department of Biochemistry at the University of Wisconsin-
Madison. Member of the American Association of Immunologist,
the American Association for the Advancement of Science,
and the American Institute of Nutrition. Chairperson for the
Department of Defense Breast Cancer Research Program in
the Cell Biology Study Section.
The Vitamin D Endocrine System and Autoimmune
Disease
Dr Hayes reviewed vitamin D3 biosynthesis, its conversion to
the steroid hormone 1,25-dihydroxyvitamin D3 and the role
this hormone has in the prevention of autoimmune diseases
such as multiple sclerosis, diabetes, inflammatory bowel
disease and arthritis. She showed how exacerbations of multi-
ple sclerosis seem to follow the lack of seasonal sunlight in the
more northern latitudes and its correlation to lower vitamin D
levels. The same trend was observed in insulin-dependent dia-
betes mellitus and irritable bowel syndrome. She then provided
data from an animal model of autoimmune encephalomyelitis
and the pro-apoptotic influence of 1,25-dihydroxyvitamin D3
on inflammatory cells leading to their selective destruction.
Mark Estes, PhD
Professor and Senior Scientist in the Department of Pediatrics,
Microbiology, and Immunology, and Pathology at the Sealy
Center for Vaccine Development at the University of Texas
Medical Branch.
Alternation in Immune Responses to Bacterial
Infection in Mice Fed Dietary Phytoestrogen Genistein
Dr Estes’area of research focused on the role of sex hormones
in modulating immune function: specifically the polarizing
effect of genestein on the Th1 versus Th2 response in the face
of infection with M. avium. His studies demonstrated that 
ER-  (estrogen eeceptor- ) signaling and dietary genistein
inhibited production of type 1 cytokines (IFN-  and inter-
leukin-18) in response to chronic M. avium infection in female
mice. IFN-  plays an important role in controlling intracellu-
lar bacterial infection and is mainly produced by T cells and
NK cells. In his research, comparison of cytokine production
in immunocompetent versus immunodeficient mice indicates
that in the setting of chronic infection with M. avium,t h e
effects of ER-  and genistein on cytokine production are
probably mediated via signaling in T cells.
Carolyn McMakin, MA, DC
Clinical Director of the Fibromyalgia and Myofascial Pain
Clinic of Portland, Oregon.
Modulation of Inflammatory Cytokines Using
Frequency Specific Therapy
Dr McMakin reviewed the use of biological resonance (FSM; fre-
quency-specific microcurrent) as it applies to the reduction of
inflammation in a mouse model and in the treatment of fibromyal-
gia associated with cervical trauma. She reviewed unpublished
animal data showing significant reductions in lipoxygenase- and
cyclooxygenase-mediated inflammation. Specifically, in a mouse
model, the ears were painted with arachidonic acid in ethanol
leading to dramatic edema that could be reduced by 70% within
4 min with the use of FSM. The rationale behind such powerful
reduction in inflammation was reviewed.
Hugh Fudenberg, MD, PhD
Chief Editor of the Journal of Clinical Immunology and
Immunopathology
Hazards of Vaccines and of the Thimerosol in them
Dr Fudenberg reviewed the evidence suggesting vaccines,
specifically measles vaccine, may be contributing to
eCAM 2005;2(1) 123developmentally delayed disorders, such as ADHD and
autism. He cited references supporting high levels of antibod-
ies in the spinal fluid of patients with infantile onset autism.
Edwin Cooper, PhD
Professor, Department of Neuroimmunology David Geffen
School of Medicine at UCLA.
Emerging Concepts in Immunology
Dr Cooper gave the keynote lecture on the field of immunol-
ogy. Reviewing its history and evolution, he summarized the
role of inflammation in the ancient literature to the present day.
He reviewed research in the field of complementary and alter-
native medicine as it relates to immune tolerance and stimula-
tion, showing the vast number of compounds being evaluated
for their potential medicinal value. He specifically reviewed
the enzyme lumbrokinase (an anticoagulant extracted from
earthworms) and its benefit in the treatment of hypercoagula-
ble states.
Shari Lieberman, PhD
Certified Nutrition Specialist, Fellow of the American College
of Nutrition, Member of the New York Academy of Science,
Author or contributing editor to many books including the
AMA’s 5th Edition of Drug Evaluations.
Nutriceuticals in the Battle Against Cancer
Dr Leiberman reviewed the role of catechins, specifically
EGCG (epigallocatechin-3-gallate), as an inhibitor of metasta-
sis by blocking matrix metalloproteinase, by specific induction
of cancer cell apoptosis and as a tyrosine kinase receptor
inhibitor. The results of studies showing its benefit in cervici-
tis, mild to moderate cervical dysplasia and HTLV-1 were
reviewed. Data on curcumin, lycopene and ascorbic acid in
cancer patients and in vitro studies were also covered.
Richard Neubauer, MD
Medical Director of Ocean Hyperbaric Neurologic Center.
Medical Graduate, University of Virginia with honors. Pioneer
of several emerging applications of hyperbaric oxygen in the
treatment of stroke.
Hyperbaric Oxygenation in Mitochondrial Cytopathies
Dr Neubauer reviewed the history of hyperbaric oxygenation
(HBO), the effect of pressurized oxygen in acute brain insult,
its effect in chronic brain insult, the mitochondrial electron
transport chain and the potential influence of HBO on gene
transcription.
Mohamed Rafi, PhD
Assistant Professor in the Department of Food Science at the
Cook College, Rutgers, University. Postdoctoral Fellow and
Research Teaching Specialist at the Cancer Institute of New
Jersey. Recipient of the Gallo Award for Outstanding Cancer
Research
A Novel Bcl-2 Phosphorylating Molecule in Licorice:
an Ultimate Answer to Cancer?
Overexpression of Bcl-2 prevents the release of cytochrome c
from the mitochondria, a critical event in the apoptotic path-
way. Bcl-2 in higher concentrations protects cells from death-
promoting stimuli, whereas its underexpression increases a
cell’s sensitivity to death. Dr Rafi reviewed his original
research on the licorice-derived polyphenol,  -hydroxy DHP
(a component of PC-SPES) showing how it induces apoptosis,
G2/M cell cycle arrest, Bcl-2 phosphorylation and altered
microtubule structure.
Michael Zeligs, MD
Founder and CEO of BioResponse Nutrients currently collab-
orating with the Chemoprevention Branch of the NIH on the
benefit of DIM in estrogen metabolism. Masters Degree on
Stress-Physiology from UC, Santa Barbara. MD Degree from
UC-Irvine.
Reversing Estrogen Dominance: Intervention with
Cruciferous Diindolylmethane (DIM)
Dr Zeligs showed how 4-hydroxy estrogen contributes to
estrogen-related disorders including breast cancer risk. He then
showed studies on the role of diindolylmethane (DIM) in increas-
ing 2-hydroxy estrogen, which is associated with specific health
benefits including reducing cancer risk and offering protection
from human papilloma virus (HPV). DIM is a potent antioxi-
dant and normalizes estrogen metabolism. Dr Zeligs presented
studies showing reduced breast and prostate cancer growth in
animals.
Richard Hansen, DMD
Dental Private Practice. Faculty member at UCLA’s Center
for Aesthetic Dentistry. Advisory Board Member: American
Preventive Medical Association.
The Oral Immune System
The oral immune system is composed of the mucosal barrier
system, which creates a large output of secretory IgA (SIgA).
If immunity is low, SIgA output is reduced and infections enter
more easily through the mucosal barrier into the blood. Oral
infections are related to heart disease, bacterial endocarditis,
stroke, diabetes and vascular inflammation. Dr Hansen out-
lined the hazards of dental materials and procedures on the
oral cavity. Harmful dental materials include mercury,
cadmium, nickel and plastics. Root canals can cause chronic
low-grade infections and chronic inflammation. TMJ and bite
stress can also force breakdown of bone and immune membranes,
which can also lead to oral infection.
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